Seoul Viosys Co. Ltd (092190)
KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 7,250.00 |
|---|---|
| 52-week range | 2,135.00 – 19,270.00 |
| Return, 1 month / 3 months | −10.6% / +29.7% |
| Return, 1 year / 3 years | +192.3% / +57.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 110.6% |
| Worst drawdown (1 year) | -76.4% |
| Average daily value traded | 1,487.85M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Seoul Viosys makes light-emitting devices built around ultraviolet and visible-light technology. Its products include ultraviolet light-emitting diodes in chip, package and module form, together with related lamps and systems. Customers use these devices for disinfection and sterilisation of air, water and surfaces, for curing of inks and coatings, and for sensing and specialty lighting applications. The company is based in Korea and serves industrial and commercial customers in markets around the world.
Seoul Viosys Co. Ltd trades under the code 092190 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Seoul Viosys Co. Ltd (092190) trades on the KOSDAQ in Korea. It last closed at KRW 7,250.00 on 19 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 529 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 192.3% and over the last three months it rose 29.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.0% | ||
| From 52-week high | -58.7% | ||
| Momentum | 94 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 29.7% | ||
| 6-month return | 106.3% | ||
| 12-month return, skipping the last month | 227.0% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 110.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -76.4% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 1,487.85M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −9.9% |
|---|---|
| 1 month | −10.6% |
| 3 months | +29.7% |
| 6 months | +106.3% |
| 1 year | +192.3% |
| 3 years | +57.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7,948.20 / 6,305.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 722.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Dec 2022 | KRW 59.0000 |
| 29 Dec 2021 | KRW 59.0000 |
| 29 Dec 2020 | KRW 143.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.